Protecting the endothelial glycocalyx in COVID-19

Abstract

Available evidence suggests that EG disruption contributes to severe COVID-19 outcomes. The therapeutic candidates presented here offer promising avenues for developing interventions that can protect and restore the EG. Further studies are urgently needed to evaluate the efficacy and safety of these candidates, whether alone or in combination, to prepare for future outbreaks and improve patient outcomes for future outbreaks.